On-slide and optical biopsy tools to find high-risk oral precancers
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy
This project uses on-slide molecular tests and light-based imaging to find which mouth lesions are most likely to become cancer for people with suspicious oral patches.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11141895 on NIH RePORTER |
What this research studies
Researchers are combining on-slide tests (molecular analyses performed on biopsy tissue) with optical imaging that highlights color and tissue changes in the mouth. They will enroll people with oral epithelial dysplasia or oral lichen planus and collect biopsy samples and clinic images during visits. The team will compare the new tools' signals with standard pathology and longer-term clinical follow-up to identify markers linked to progression. The aim is to make it easier to spot high-risk lesions so patients get earlier treatment and avoid unnecessary frequent follow-ups.
Who could benefit from this research
Good fit: People with suspicious red or white patches in the mouth, including diagnosed oral epithelial dysplasia or oral lichen planus, who are seen by dental, ENT, or cancer clinics.
Not a fit: People without oral lesions or those who already have invasive oral cancer are unlikely to benefit from these early-detection tools.
Why it matters
Potential benefit: If successful, these tools could help doctors identify dangerous precancerous mouth lesions earlier, enabling quicker treatment and reducing unnecessary monitoring for low-risk cases.
How similar studies have performed: Some optical imaging and molecular tests have shown promise for spotting suspicious areas, but combining on-slide molecular analysis with optical biopsy to predict progression is relatively new.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Lei, Yu Leo — University of Tx Md Anderson Can Ctr
- Study coordinator: Lei, Yu Leo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.